FTC Told DOD Designation Helps Illumina-Grail Deal Appeal

By Matthew Perlman (November 30, 2022, 7:01 PM EST) — The Federal Trade Commission is considering whether a recent decision by the U.S. Department of Defense designating BGI Genomics as a Chinese military company bolsters attempts by agency staff to revive their challenge to the purchase of cancer-testing outfit Grail by DNA sequencing giant Illumina….

Read more

Explore the site

More from the blog

Latest News